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Both the Neuromate robotic (Renishaw) arm and the Rosa robotic arm (Rosa) are routinely used in a variety of procedures: depth electrode for epilepsy, deep brain stimulation, endoscopic procedures, etc.
Generally, these are frame-based procedures (frame used for registration purpose and to guarantee sub-millimetric accuracy) and only recently frameless registration has been integrated into robotic arm software with satisfactory results [1] [2] [3] .
In the present study, the authors report their experience with brain biopsies (mainly intrinsic lesions) using a frameless registration mode and the Rosa robotic arm.
The overall results are matching with those achieved with a frame-based technique (either frame or frame-based robotic arm) and are better than those achieved with a standard frameless procedure (image-guided Medtronic or Brainlab).
The overall operating time is matching standard frameless procedures with an added improvement in accuracy.
The future of stereotactic procedure is frameless registration and the utilization of robotic arm; this, in the short term, will lead to an expansion of robotic-assisted neurosurgical procedures in all neurosurgical sub-specialties (functional, oncology, skull-based, etc.) and, in long-term, will allow automatization of neurosurgical procedures in the integration of realtime imaging. Naturally, this will require a significant technological improvement but the current platforms such as Rosa and Neuromate both offer a very good starting point.
